Report - Volume 14 Number 5 7 March 2014 Pages …amnl.mie.utoronto.ca/data/J101.pdfearly stagein drug developmentprocess to define safety profile and avoid cost escalation. Despite the exceptional

Please pass captcha verification before submit form